School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Keerthi Gogineni MD, MSHP

  • Department of Hematology and Medical Oncology
    Associate Professor
  • keerthi.gogineni@emory.edu
Head shot of Keerthi Gogineni

Overview

Board certified in hematology and medical oncology, Dr. Gogineni sees patients with breast malignancies and is a member of the clinical care team in the Glenn Family Breast Cetner at Winship Cancer Institute. She actively collaborates with other Winship members in clinical trials and health policy research.

Dr. Gogineni serves as Associate Director of the Hematology and Medical Oncology Fellowship Program and as Co-Vice Chair of Diversity, Equity, and Inclusion in the Department of Hematology and Medical Oncology.

Dr. Gogineni is conducting research that evaluates and improves access to oncology care for disenfranchised patients.

Dr. Gogineni has presented the results of her health policy research at national meetings, such as the American Society for Clinical Oncology, and published her work in peer-reviewed journals such as the New England Journal of Medicine.

Dr. Gogineni was awarded a Young Investigator Award from the American Society of Clinical Oncology and a Pfizer Research Fellowship in Bioethics for her research. As a fellow at the University of Pennsylvania, she received the Hematology-Oncology Jane Alavi Award for Clinical Excellence from the Department of Medicine.

Academic Appointment

  • Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Education

Degrees

  • MD from University of Maryland, College Park, College Park

Research

Publications

  • Redlining-associated methylation in breast tumors: the impact of contemporary structural racism on the tumor epigenome.
    Front Oncol Volume: 13 Page(s): 1154554
    01/01/2023 Authors: Miller-Kleinhenz JM; Moubadder L; Beyer KM; Zhou Y; Gaglioti AH; Collin LJ; Gohar J; Do W; Conneely K; Krishnamurti U
  • Barriers to breast cancer screening in Atlanta, GA: results from the Pink Panel survey at faith-based institutions.
    Cancer Causes Control Volume: 33 Page(s): 1465 - 1472
    12/01/2022 Authors: Balenger A; Seth G; Bhattarai S; Collin LJ; McCullough L; Gogineni K; Subhedar P; Ellison C; Khan U; Swahn MH
  • Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90).
    Cardiovasc Intervent Radiol Volume: 45 Page(s): 1725 - 1734
    11/01/2022 Authors: Wu R; Gogineni K; Meisel J; Szabo S; Thirunavu M; Friend S; Bercu Z; Sethi I; Natarajan N; Switchenko J
  • Association of Race and Area Deprivation With Breast Cancer Survival Among Black and White Women in the State of Georgia.
    JAMA Netw Open Volume: 5 Page(s): e2238183
    10/03/2022 Authors: Luningham JM; Seth G; Saini G; Bhattarai S; Awan S; Collin LJ; Swahn MH; Dai D; Gogineni K; Subhedar P
  • A spatial attention guided deep learning system for prediction of pathological complete response using breast cancer histopathology images.
    Bioinformatics Volume: 38 Page(s): 4605 - 4612
    09/30/2022 Authors: Duanmu H; Bhattarai S; Li H; Shi Z; Wang F; Teodoro G; Gogineni K; Subhedar P; Kiraz U; Janssen EAM
  • Drivers of racial, regional, and socioeconomic disparities in late-stage breast cancer mortality.
    Cancer Volume: 128 Page(s): 3370 - 3382
    09/15/2022 Authors: Moubadder L; Collin LJ; Nash R; Switchenko JM; Miller-Kleinhenz JM; Gogineni K; Ward KC; McCullough LE
  • Individualizing Adjuvant Therapy in Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Node-Positive Breast Cancer.
    JCO Oncol Pract Volume: 18 Page(s): 247 - 251
    04/01/2022 Authors: Gogineni K; Kalinsky K
  • Pilot Feasibility Study of a Video Intervention to Educate Patients with Breast Cancer About Clinical Trials.
    J Cancer Educ Volume: 37 Page(s): 387 - 394
    04/01/2022 Authors: Yeager KA; Bai J; Gogineni K; Meisel JL; Kweon J; Bruner DW; Waldrop-Valverde D
  • Neighborhood characteristics and breast tumor methylation: using epigenomics to explore cancer outcome disparities.
    Breast Cancer Res Treat Volume: 191 Page(s): 653 - 663
    02/01/2022 Authors: Gohar J; Do WL; Miller-Kleinhenz J; Conneely K; Krishnamurti U; D'Angelo O; Gogineni K; Torres M; Gabram-Mendola S; McCullough LE
  • Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta.
    J Natl Compr Canc Netw Volume: 19 Page(s): 1242 - 1251
    08/16/2021 Authors: Collin LJ; Yan M; Jiang R; Gogineni K; Subhedar P; Ward KC; Switchenko JM; Lipscomb J; Miller-Kleinhenz J; Torres MA
  • Crown-Like Structures in Breast Adipose Tissue: Early Evidence and Current Issues in Breast Cancer.
    Cancers (Basel) Volume: 13
    05/06/2021 Authors: Maliniak ML; Miller-Kleinhenz J; Cronin-Fenton DP; Lash TL; Gogineni K; Janssen EAM; McCullough LE
  • Spatial Attention-Based Deep Learning System for Breast Cancer Pathological Complete Response Prediction with Serial Histopathology Images in Multiple Stains.
    Volume: 12908 Page(s): 550 - 560
    01/01/2021 Authors: Duanmu H; Bhattarai S; Li H; Cheng CC; Wang F; Teodoro G; Janssen EAM; Gogineni K; Subhedar P; Aneja R
  • The Impact of Genetic Counseling Educational Tools on Patients' Knowledge of Molecular Testing Terminology.
    J Cancer Educ Volume: 35 Page(s): 864 - 870
    10/01/2020 Authors: McDaniels BA; Hianik RS; Bellcross C; Shaib WL; Switchenko J; Dixon MD; Meisel JL; Gogineni K; Pentz RD
  • Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer.
    Breast Cancer Res Volume: 22 Page(s): 65
    06/17/2020 Authors: Maliniak ML; Cheriyan AM; Sherman ME; Liu Y; Gogineni K; Liu J; He J; Krishnamurti U; Miller-Kleinhenz J; Ashiqueali R
  • A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ.
    Clin Cancer Res Volume: 26 Page(s): 2898 - 2907
    06/15/2020 Authors: Mittal K; Toss MS; Wei G; Kaur J; Choi DH; Melton BD; Osan RM; Miligy IM; Green AR; Janssen EAM
  • Presence of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White breast cancer patients
    Volume: 29
    06/01/2020 Authors: Cheriyan AM; Sherman ME; Liu Y; Gogineni K; Liu J; He J; Krishnamurti U; Ashiqueali R; He J; Yacoub R
  • Outcomes for black versus white women with stage IV breast cancer enrolled on investigator-initiated clinical trials at Emory.
    Volume: 38
    05/20/2020 Authors: Ekpo P; Torres MA; Rupji M; Switchenko JM; Subhedar P; Gogineni K; Bhave MA
  • Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
    Breast Cancer Res Treat Volume: 181 Page(s): 135 - 144
    05/01/2020 Authors: Do WL; Conneely K; Gabram-Mendola S; Krishnamurti U; D'Angelo O; Miller-Kleinhenz J; Gogineni K; Torres M; McCullough LE
  • Intensity-Modulated Radiation Therapy in Breast Cancer Patients Following the Release of a Choosing Wisely Recommendation.
    J Natl Cancer Inst Volume: 112 Page(s): 314 - 317
    03/01/2020 Authors: Torres MA; Gogineni K; Howard DH
  • Quadruple-Negative Breast Cancer: An Uneven Playing Field.
    JCO Glob Oncol Volume: 6 Page(s): 233 - 237
    02/01/2020 Authors: Saini G; Bhattarai S; Gogineni K; Aneja R
  • Safety and efficacy of extended dosing intervals of denosumab in patients with solid cancers and bone metastases: a retrospective study.
    Ther Adv Med Oncol Volume: 12 Page(s): 1758835920982859
    01/01/2020 Authors: Abousaud AI; Barbee MS; Davis CC; Caulfield SE; Wang Z; Boykin A; Carthon BC; Gogineni K
  • Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
    PLoS One Volume: 15 Page(s): e0232581
    01/01/2020 Authors: Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
  • Race differences in cardiovascular disease and breast cancer mortality among US women diagnosed with invasive breast cancer.
    Int J Epidemiol Volume: 48 Page(s): 1897 - 1905
    12/01/2019 Authors: Troeschel AN; Liu Y; Collin LJ; Bradshaw PT; Ward KC; Gogineni K; McCullough LE
  • Panoptic View of Prognostic Models for Personalized Breast Cancer Management.
    Cancers (Basel) Volume: 11
    09/07/2019 Authors: Saini G; Mittal K; Rida P; Janssen EAM; Gogineni K; Aneja R
  • Racial Disparities in Breast Cancer Outcomes in the Metropolitan Atlanta Area: New Insights and Approaches for Health Equity.
    JNCI Cancer Spectr Volume: 3 Page(s): pkz053
    09/01/2019 Authors: Collin LJ; Jiang R; Ward KC; Gogineni K; Subhedar PD; Sherman ME; Gaudet MM; Breitkopf CR; D'Angelo O; Gabram-Mendola S
  • Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer.
    Clin Breast Cancer Volume: 19 Page(s): 188 - 196
    06/01/2019 Authors: Paplomata E; Zelnak A; Santa-Maria CA; Liu Y; Gogineni K; Li X; Moreno CS; Chen Z; Kaklamani V; O'Regan RM
  • Obesity and cancer treatment efficacy: Existing challenges and opportunities.
    Cancer Volume: 125 Page(s): 1588 - 1592
    05/15/2019 Authors: Ross KH; Gogineni K; Subhedar PD; Lin JY; McCullough LE
  • Identifying practice patterns in the utilization of FDG PET/CT for staging breast cancer patients at a safety net hospital
    Volume: 26 Page(s): 255 - 256
    05/01/2019 Authors: Tran H; Short J; Subhedar P; Okoli J; Gogineni K; Paplomata E; Lin J; Yu D; Gabram-Mendola S; Arciero C
  • US Cancer Centers of Excellence Strategies for Increased Inclusion of Racial and Ethnic Minorities in Clinical Trials.
    J Oncol Pract Volume: 15 Page(s): e289 - e299
    04/01/2019 Authors: Regnante JM; Richie NA; Fashoyin-Aje L; Vichnin M; Ford M; Roy UB; Turner K; Hall LL; Gonzalez E; Esnaola N
  • NEOTALA: an open-label, single-arm, multi-center, phase 2 study of talazoparib for neoadjuvant treatment of germline BRCA1/2 mutation patients with early-stage triple negative breast cancer (TNBC)
    Volume: 44 Page(s): S73 - S74
    03/01/2019 Authors: Litton J; Symmans F; Gogineni K; Saltzman M; Telli ML; Usha L; Chakrabarti J; Tudor IC; Quek RGW; Czibere A
  • A phase 2, open-label, single-arm, multi-center study of talazoparib for neoadjuvant treatment of germline BRCA1/2 mutation patients with early-stage triple-negative breast cancer (TNBC)
    Volume: 79
    02/01/2019 Authors: Litton J; Symmans F; Gogineni K; Saltzman M; Telli ML; Usha L; Chakrabarti J; Tudor IC; Quek RG; Czibere A
  • Oncotype DX recurrence score implications for disparities in chemotherapy and breast cancer mortality in Georgia.
    NPJ Breast Cancer Volume: 5 Page(s): 32
    01/01/2019 Authors: Collin LJ; Yan M; Jiang R; Ward KC; Crawford B; Torres MA; Gogineni K; Subhedar PD; Puvanesarajah S; Gaudet MM
  • Patterns of BRCA testing at a safety net compared to a university hospital
    Volume: 27 Page(s): 124 - 125
    07/01/2018 Authors: Smith DJ; Sauter C; Zhang C; Chen Z; Gogineni K
  • Racial/ethnic differences in all-cause and cause-specific mortality patterns among a cohort of invasive U. S. breast cancer patients
    Volume: 78
    07/01/2018 Authors: Troeschel AN; Liu Y; Collin L; Ward K; Gogineni K; McCullough L
  • Phase 1 study of CB-839, a first-in-class oral inhibitor of glutaminase, in combination with paclitaxel in patients with advanced triple negative breast cancer
    Volume: 78
    02/01/2018 Authors: Kalinsky K; Harding JJ; DeMichele A; Infante JR; Gogineni K; Owonikoko TK; Isakoff S; Iliopoulos O; Patel MR; Munster P
  • Phase 2 trial of everolimus and/or trastuzumab in hormone refractory, hormone receptor (HR)-positive, HER2-normal metastatic breast cancer (MBC)
    Volume: 77
    02/01/2017 Authors: Paplomata E; Gogineni K; Meisel J; Santa-Maria C; Yuan L; Kramer J; Li XB; Zelnak A; Pakkala S; Kaklamani V
  • Cognitive Behavioral Therapy for Insomnia, Mindfulness, and Yoga in Patients With Breast Cancer with Sleep Disturbance: A Literature Review.
    Breast Cancer (Auckl) Volume: 11 Page(s): 1178223417745564
    01/01/2017 Authors: Zeichner SB; Zeichner RL; Gogineni K; Shatil S; Ioachimescu O
  • Ductal carcinoma in situ: How much is too much?
    Cancer Volume: 122 Page(s): 2780 - 2782
    09/15/2016 Authors: Gogineni K
  • Multi-template analysis in metastatic breast cancer blood samples
    Volume: 76
    07/01/2016 Authors: Strauss WM; Carter C; Klem E; Simmons J; Gogineni K; O'Regan R; Austin L; Dempsey PW; Cristofanilli M
  • Analysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkers.
    Oncotarget Volume: 7 Page(s): 26724 - 26738
    05/03/2016 Authors: Strauss WM; Carter C; Simmons J; Klem E; Goodman N; Vahidi B; Romero J; Masterman-Smith M; O'Regan R; Gogineni K
  • A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer.
    Breast Cancer (Auckl) Volume: 10 Page(s): 25 - 36
    01/01/2016 Authors: Zeichner SB; Terawaki H; Gogineni K
  • A phase II trial of exemestane and ruxolitinib for aI-resistant ER plus breast cancer: Interim safety, efficacy, and biomarker analysis
    Volume: 75
    08/01/2015 Authors: DeMichelel AM; Colameco CB; Kalota A; Troxel AB; Holmes R; Cimildoro R; Zafman K; Fox KR; Domchek SM; Gogineni K
  • The Demanding Patient Revisited--Reply.
    JAMA Oncol Volume: 1 Page(s): 544
    07/01/2015 Authors: Gogineni K; Shuman KL; Gabler NB; Emanuel EJ
  • Benefits and risks of contralateral prophylactic mastectomy in women undergoing treatment for sporadic unilateral breast cancer: a decision analysis.
    Breast Cancer Res Treat Volume: 152 Page(s): 217 - 226
    07/01/2015 Authors: Lester-Coll NH; Lee JM; Gogineni K; Hwang W-T; Schwartz JS; Prosnitz RG
  • Patient Demands and Requests for Cancer Tests and Treatments.
    JAMA Oncol Volume: 1 Page(s): 33 - 39
    04/01/2015 Authors: Gogineni K; Shuman KL; Chinn D; Gabler NB; Emanuel EJ
  • Making cuts to Medicare: the views of patients, physicians, and the public.
    J Clin Oncol Volume: 33 Page(s): 846 - 853
    03/10/2015 Authors: Gogineni K; Shuman K; Chinn D; Weber A; Cosenza C; Colten ME; Emanuel EJ
  • CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment.
    Clin Cancer Res Volume: 21 Page(s): 995 - 1001
    03/01/2015 Authors: DeMichele A; Clark AS; Tan KS; Heitjan DF; Gramlich K; Gallagher M; Lal P; Feldman M; Zhang P; Colameco C
  • Patient demand for care: How much does this contribute to inappropriate tests and treatments?
    Volume: 32
    05/20/2014 Authors: Gogineni K; Chinn D; Shuman K; Emanuel EJ
  • A phase I trial of palbociclib and paclitaxel in metastatic breast cancer.
    Volume: 32
    05/20/2014 Authors: Clark AS; O'Dwyer PJ; Heitjan D; Lal P; Feldman MD; Gallagher M; Redlinger C; Colameco C; Lewis D; Zafman K
  • Survey of oncologists about shortages of cancer drugs.
    N Engl J Med Volume: 369 Page(s): 2463 - 2464
    12/19/2013 Authors: Gogineni K; Shuman KL; Emanuel EJ
  • Biomarkers to predict response to the CDK 416 inhibitor, palbociclib (PD 0332991) in a single-agent phase II trial in advanced breast cancer
    CANCER RESEARCH Volume: 73
    12/15/2013 Authors: Clark AS; Lal P; Tan KS; Heitjan DF; Feldman M; Zhang P; Gallagher M; Domchek S; Gogineni K; Keefe S
  • Ventricular-Vascular Coupling Predicts Cardiotoxicity in Breast Cancer Patients Treated With Doxorubicin or Trastuzumab
    Volume: 128
    11/26/2013 Authors: Murthy A; Alpert C; Luo L; French B; Plappert T; Khan A; Sutton MSJ; Clark A; Gogineni K; Fox K
  • Impact of oncology drug shortages.
    J Clin Oncol Volume: 31 Page(s): CRA6510
    06/20/2013 Authors: Shuman K; Chinn D; Gogineni K
  • Impact of oncology drug shortages.
    Volume: 31
    06/20/2013 Authors: Emanuel EJ; Shuman K; Chinn D; Gogineni K
  • Patient, public, and oncologists' attitudes toward rationing medical care
    Volume: 31
    05/20/2013 Authors: Gogineni K; Shuman K; Chinn D; Cosenza C; Colten ME; Fowler FJ; Emanuel EJ
  • Impact of oncology drug shortages
    Volume: 31
    05/20/2013 Authors: Emanuel EJ; Shuman K; Chinn D; Gogineni K
  • Current approaches to the management of Her2-negative metastatic breast cancer.
    Breast Cancer Res Volume: 14 Page(s): 205
    04/10/2012 Authors: Gogineni K; DeMichele A
  • A Phase II Trial of the CDK 4/6 Inhibitor PD0332991 in Women with Advanced Breast Cancer
    Volume: 71
    12/15/2011 Authors: DeMichele A; Clark A; Randolph S; Christensen J; Gallagher M; Lal P; Feldman M; Zhang P; Perini R; Velders L
  • A Decision Analysis of Contralateral Prophylactic Mastectomy in Women Undergoing Treatment for Sporadic Unilateral Breast Cancer
    Volume: 71
    12/15/2011 Authors: Lester-Coll NH; Lee JM; Gogineni K; Hwang W-T; Schwartz JS; Prosnitz RG
  • Appointment (appt) access for new cancer patients (pts).
    J Clin Oncol Volume: 29 Page(s): 6128
    05/20/2011 Authors: Gogineni K; Armstrong K
  • HIV testing and barriers to testing among pregnant mothers in Rhode Island
    PEDIATRIC RESEARCH Volume: 45 Page(s): 171A - 171A
    04/01/1999 Authors: Pugatch D; Scott K; Feller A; Gogineni K; Ramratnam M; Flanigan T; Smith P
  • Breast cancer: An attempt to develop antibodies specific for tyrosine-phosphorylated SHC as a better prognostic indicator
    MOLECULAR BIOLOGY OF THE CELL Volume: 8 Page(s): 1920 - 1920
    11/01/1997 Authors: Williams TM; Gogineni K; Frackelton AR
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements